Drugs Causing Bladder Cancer ⚡Mnemonic⚡

Mnemonic :  BLADDER CANCER

B – Busulfan: This alkylating agent used in chemotherapy has been linked to bladder cancer in some studies.

L – Long-acting Pioglitazone: Some studies suggest that long-term use of pioglitazone, a medication for type 2 diabetes, may increase the risk of bladder cancer.

A – Actos (generic name: Pioglitazone): Pioglitazone, commonly used to treat diabetes, has been associated with an elevated risk of bladder cancer.

D – Diuretics (e.g., Hydrochlorothiazide): Certain diuretics, particularly hydrochlorothiazide, have been linked to an increased risk of bladder cancer, especially with long-term use.

D – Dapagliflozin: This medication, used to treat type 2 diabetes, has been associated with an increased risk of bladder cancer in some studies.

E – Ertugliflozin: Similar to dapagliflozin, ertugliflozin, a medication for type 2 diabetes, has been linked to bladder cancer in some research.

R – Retinoids: Some studies have suggested that certain retinoid medications may be associated with an elevated risk of bladder cancer.

C – Cyclophosphamide: This chemotherapy drug is known to increase the risk of bladder cancer, especially with prolonged use.

A – Analgesics (e.g., Phenacetin): Phenacetin, a pain reliever, has been linked to bladder cancer when used over an extended period.

N – Nitrofurantoin: This antibiotic has been associated with an increased risk of bladder cancer, particularly with long-term use.

C – Chemotherapy drugs: Some chemotherapy agents, in addition to cyclophosphamide mentioned earlier, can also raise the risk of bladder cancer.

E – Ephedrine: Though not commonly used today, ephedrine has been implicated in bladder cancer in some studies.

R – (blank)